Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 1,481–1,500 of 17,937 drug recalls

Drug Recall Ongoing Historical recordClass I

Hard Steel Capsules packaged in 1 count blister packs in boxes of 10, 20 and 30, Manufactured in U.S.A.

by Supercore Products Group Inc.

Reason
Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.
Recall initiated
July 12, 2024
Reported by FDA
October 9, 2024
Distribution
Nationwide US (2014), Israel (2), Canada (12), Republic of Kosovo (1), Pakistan (1), Australia (3), Morocco (1), United Kingdom (1)

View recall →

Drug Recall Ongoing Historical recordClass III

Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only, a) 30 gm Tube, NDC 68462-0455-35; b) 45 gm Tube, NDC 68462-0455-47; c) 100 gm Tube, NDC 68462-0455-94, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.

by Glenmark Pharmaceuticals Inc., USA

Reason
Defective Container: Firm received complaints of broken tube at the seal.
Recall initiated
September 30, 2024
Reported by FDA
October 9, 2024
Distribution
Nationwide in the US.

View recall →

Drug Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01.

by Nivagen Pharmaceuticals Inc

Reason
Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
Recall initiated
September 24, 2024
Reported by FDA
October 9, 2024
Distribution
Nationwide within the U.S

View recall →

Drug Recall Ongoing Historical recordClass II

Mycophenolic Acid Delayed-Release Tablets USP, 360 mg, Rx Only, 120 Tablets per bottle, Manufactured by Alkem Laboratories, LTD, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-427-12.

by Ascend Laboratories, LLC

Reason
Failed Dissolution Specifications
Recall initiated
September 3, 2024
Reported by FDA
October 2, 2024
Distribution
Nationwide in the USA and PR

View recall →

Drug Recall Ongoing Historical recordClass II

EnviroClean Hand Sanitizer Gel (isopropyl alcohol 70% v/v), 473 mL (16 fl. oz.) bottles, EnviroServe Chemicals Inc., 603 South Wilson Avenue, Dunn NC, 28334, NDC 76563-3010-1

by EnviroServe Chemicals Inc.

Reason
CGMP deviations
Recall initiated
September 18, 2024
Reported by FDA
October 2, 2024
Distribution
Product was sent to one distributor in North Carolina.

View recall →

Drug Recall Ongoing Historical recordClass II

Infla-650 Herbal Dietary Supplement, 700mg, packaged in pouches containing 60 capsules, Distributed by: Guru Inc., 4370 Lawrenceville Hwy NW, P.O. Box 2204, Lilburn, GA 30047-1100, USA. Ph.: 872 216 1566, http://www.dalayurevda.com, Made in India, UPC: 042535355019

by Guru Inc.

Reason
Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.
Recall initiated
June 26, 2024
Reported by FDA
October 2, 2024
Distribution
Retail: South Carolina, North Carolina, Ohio; Consumer level: Nationwide within USA

View recall →

Drug Recall Ongoing Historical recordClass II

Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230312042

by AbbVie Inc.

Reason
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Recall initiated
September 16, 2024
Reported by FDA
October 2, 2024
Distribution
Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)

View recall →

Drug Recall Ongoing Historical recordClass II

Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230667043,

by AbbVie Inc.

Reason
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Recall initiated
September 16, 2024
Reported by FDA
October 2, 2024
Distribution
Nationwide in the USA, Foreign Consignees (Austrailia, Canada, Great Britain)

View recall →

Drug Recall Terminated Historical recordClass II

Pyridoxine HCL (B6) Injection Solution, 100mg/mL, 30 mL Sterile Multiple-Dose Vial, For IM or IV use only, RX Only, Compounded by: Empower Pharmacy 5980 W Sam Houston Pkwy N Ste 300, Houston, TX 77041 NDC 72627-2424-1.

by Empower Pharmacy

Reason
Lack of Assurance of Sterility
Recall initiated
September 5, 2024
Reported by FDA
October 2, 2024
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Vivier Sheer SPF 30 Mineral With Antioxidants (titanium dioxide 10% and zinc oxide 8%) packaged in 60 ml/2 fl oz, Vivier Canada Inc. / Mfd. for Vivier Pharma, Vaudereull-Dorion OC Canada, J7V 5V5, Champlain, NY USA 12919, Made in Canada, NDC 67226-2232-6. SKU 10-160-ZZ-80059-R

by Vivier Pharma, Inc.

Reason
Microbial Contamination of Non-Sterile Product
Recall initiated
September 3, 2024
Reported by FDA
October 2, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bottle, Rx only, MFG: Bausch & Lomb, NDC 24208-730-06

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
Temperature abuse: Products exposed to improper temperature above drug label specifications.
Recall initiated
September 11, 2024
Reported by FDA
October 2, 2024
Distribution
Product was distributed to two medical facilities in MD and VA.

View recall →

Drug Recall Completed Historical recordClass II

Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.

by Glenmark Pharmaceuticals Inc., USA

Reason
Subpotent Drug
Recall initiated
August 30, 2024
Reported by FDA
October 2, 2024
Distribution
Product was distributed nationwide within the United States.

View recall →

Drug Recall Ongoing Historical recordClass III

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01

by Rubicon Research Private Limited

Reason
Discoloration
Recall initiated
August 24, 2024
Reported by FDA
September 25, 2024
Distribution
Nationwide in the US

View recall →

Drug Recall Terminated Historical recordClass III

Just Right 5000, 1.1% Sodium Fluoride, Candy Apple Flavor, Net Wt. 3.4oz (97g), Rx Only, Manufactured for Elevate Oral Care, LLC in the U.S.A with imported pump, 346 Pike Rd, Suite 5, West Palm Beach, FL 33411, NDC 57511-002-1

by Elevate Oral Care

Reason
LABELING: LABEL MIX-UP.
Recall initiated
August 20, 2024
Reported by FDA
September 18, 2024
Distribution
120 direct customers, Nationwide US. No foreign, DOD/VA.

View recall →

Drug Recall Ongoing Historical recordClass II

BARRIER THERAPY SKIN PROTECTANT CREAM (1% colloidal oatmeal), 10 FL OZ/296 ML- tube, Distributed By: Prequel, LOS ANGELES, CA 90069. UPC 8 10129 11007 4

by PREQUEL SKIN

Reason
Microbial contamination of non-sterile Products -
Recall initiated
August 28, 2024
Reported by FDA
September 18, 2024
Distribution
Distributed nationwide in USA and on line

View recall →

Drug Recall Ongoing Historical recordClass II

TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass II

SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-01

by ProRx LLC

Reason
Lack of Assurance of Sterility
Recall initiated
August 22, 2024
Reported by FDA
September 11, 2024
Distribution
Nationwide in the USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.